Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE

S. L. Dabora, I. Sigalas, F. Hall, G. Eng, Jan Vijg, D. J. Kwiatkowski

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of benign tumors in multiple organs often causing serious neurologic impairment. To develop a reliable genetic test for TSC, two-dimensional electrophoresis with denaturing gradient gel electrophoresis (2D DGGE) has been developed to detect mutation in TSC1. The 23 exons of TSC1 were amplified using two rounds of PCR. In the first round, all coding regions of TSC1 were amplified in four fragments ranging in size from 7.4 kb to 9.9 kb. In the second round, 32 fragments representing 23 exons were amplified using primers designed to avoid overlapping fragments and with a GC clamp on one end to optimise melting characteristics. These exon fragments were then separated by size in the first dimension using a polyacrylamide gel, and by melting characteristics in the second dimension using a urea/formamide gradient to yield 32 distinct bands. If a mutation is present, four bands instead of one, are typically observed. During the development of this assay, we analysed 63 patient samples with known TSC1 mutation from prior studies. These 63 patients had 68 known mutations or polymorphisms. With DGGE, all 68 of these were identified (45 point mutations, 3 small insertions, 20 small deletions) and an additional 27 single base variants were discovered. To evaluate the assay, we analysed 19 of these samples in a blinded study. In the blinded analysis, 19/20 (95%) known mutations or polymorphisms were detected. The single missed mutation in the blinded analysis could be identified in retrospect and the assay was modified accordingly. During this study, we identified 2 new mutations (exon 8 and exon 15), a new polymorphism (intron 4), and the first variant identified in a non-coding exon (exon 2).

Original languageEnglish (US)
Pages (from-to)491-504
Number of pages14
JournalAnnals of Human Genetics
Volume62
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Electrophoresis
Exons
Mutation
DNA
Tuberous Sclerosis
Freezing
Denaturing Gradient Gel Electrophoresis
Point Mutation
Introns
Nervous System
Urea
Polymerase Chain Reaction
Neoplasms

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE. / Dabora, S. L.; Sigalas, I.; Hall, F.; Eng, G.; Vijg, Jan; Kwiatkowski, D. J.

In: Annals of Human Genetics, Vol. 62, No. 6, 1998, p. 491-504.

Research output: Contribution to journalArticle

Dabora, S. L. ; Sigalas, I. ; Hall, F. ; Eng, G. ; Vijg, Jan ; Kwiatkowski, D. J. / Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE. In: Annals of Human Genetics. 1998 ; Vol. 62, No. 6. pp. 491-504.
@article{7a78706b84c142728d0c1e3474df1d69,
title = "Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE",
abstract = "Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of benign tumors in multiple organs often causing serious neurologic impairment. To develop a reliable genetic test for TSC, two-dimensional electrophoresis with denaturing gradient gel electrophoresis (2D DGGE) has been developed to detect mutation in TSC1. The 23 exons of TSC1 were amplified using two rounds of PCR. In the first round, all coding regions of TSC1 were amplified in four fragments ranging in size from 7.4 kb to 9.9 kb. In the second round, 32 fragments representing 23 exons were amplified using primers designed to avoid overlapping fragments and with a GC clamp on one end to optimise melting characteristics. These exon fragments were then separated by size in the first dimension using a polyacrylamide gel, and by melting characteristics in the second dimension using a urea/formamide gradient to yield 32 distinct bands. If a mutation is present, four bands instead of one, are typically observed. During the development of this assay, we analysed 63 patient samples with known TSC1 mutation from prior studies. These 63 patients had 68 known mutations or polymorphisms. With DGGE, all 68 of these were identified (45 point mutations, 3 small insertions, 20 small deletions) and an additional 27 single base variants were discovered. To evaluate the assay, we analysed 19 of these samples in a blinded study. In the blinded analysis, 19/20 (95{\%}) known mutations or polymorphisms were detected. The single missed mutation in the blinded analysis could be identified in retrospect and the assay was modified accordingly. During this study, we identified 2 new mutations (exon 8 and exon 15), a new polymorphism (intron 4), and the first variant identified in a non-coding exon (exon 2).",
author = "Dabora, {S. L.} and I. Sigalas and F. Hall and G. Eng and Jan Vijg and Kwiatkowski, {D. J.}",
year = "1998",
doi = "10.1017/S0003480099007198",
language = "English (US)",
volume = "62",
pages = "491--504",
journal = "Annals of Human Genetics",
issn = "0003-4800",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE

AU - Dabora, S. L.

AU - Sigalas, I.

AU - Hall, F.

AU - Eng, G.

AU - Vijg, Jan

AU - Kwiatkowski, D. J.

PY - 1998

Y1 - 1998

N2 - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of benign tumors in multiple organs often causing serious neurologic impairment. To develop a reliable genetic test for TSC, two-dimensional electrophoresis with denaturing gradient gel electrophoresis (2D DGGE) has been developed to detect mutation in TSC1. The 23 exons of TSC1 were amplified using two rounds of PCR. In the first round, all coding regions of TSC1 were amplified in four fragments ranging in size from 7.4 kb to 9.9 kb. In the second round, 32 fragments representing 23 exons were amplified using primers designed to avoid overlapping fragments and with a GC clamp on one end to optimise melting characteristics. These exon fragments were then separated by size in the first dimension using a polyacrylamide gel, and by melting characteristics in the second dimension using a urea/formamide gradient to yield 32 distinct bands. If a mutation is present, four bands instead of one, are typically observed. During the development of this assay, we analysed 63 patient samples with known TSC1 mutation from prior studies. These 63 patients had 68 known mutations or polymorphisms. With DGGE, all 68 of these were identified (45 point mutations, 3 small insertions, 20 small deletions) and an additional 27 single base variants were discovered. To evaluate the assay, we analysed 19 of these samples in a blinded study. In the blinded analysis, 19/20 (95%) known mutations or polymorphisms were detected. The single missed mutation in the blinded analysis could be identified in retrospect and the assay was modified accordingly. During this study, we identified 2 new mutations (exon 8 and exon 15), a new polymorphism (intron 4), and the first variant identified in a non-coding exon (exon 2).

AB - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of benign tumors in multiple organs often causing serious neurologic impairment. To develop a reliable genetic test for TSC, two-dimensional electrophoresis with denaturing gradient gel electrophoresis (2D DGGE) has been developed to detect mutation in TSC1. The 23 exons of TSC1 were amplified using two rounds of PCR. In the first round, all coding regions of TSC1 were amplified in four fragments ranging in size from 7.4 kb to 9.9 kb. In the second round, 32 fragments representing 23 exons were amplified using primers designed to avoid overlapping fragments and with a GC clamp on one end to optimise melting characteristics. These exon fragments were then separated by size in the first dimension using a polyacrylamide gel, and by melting characteristics in the second dimension using a urea/formamide gradient to yield 32 distinct bands. If a mutation is present, four bands instead of one, are typically observed. During the development of this assay, we analysed 63 patient samples with known TSC1 mutation from prior studies. These 63 patients had 68 known mutations or polymorphisms. With DGGE, all 68 of these were identified (45 point mutations, 3 small insertions, 20 small deletions) and an additional 27 single base variants were discovered. To evaluate the assay, we analysed 19 of these samples in a blinded study. In the blinded analysis, 19/20 (95%) known mutations or polymorphisms were detected. The single missed mutation in the blinded analysis could be identified in retrospect and the assay was modified accordingly. During this study, we identified 2 new mutations (exon 8 and exon 15), a new polymorphism (intron 4), and the first variant identified in a non-coding exon (exon 2).

UR - http://www.scopus.com/inward/record.url?scp=0032447787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032447787&partnerID=8YFLogxK

U2 - 10.1017/S0003480099007198

DO - 10.1017/S0003480099007198

M3 - Article

C2 - 10363127

AN - SCOPUS:0032447787

VL - 62

SP - 491

EP - 504

JO - Annals of Human Genetics

JF - Annals of Human Genetics

SN - 0003-4800

IS - 6

ER -